Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.78 - $3.64 $26,698 - $54,596
14,999 New
14,999 $29,000
Q3 2022

Nov 14, 2022

SELL
$2.89 - $5.32 $13,640 - $25,110
-4,720 Reduced 21.23%
17,513 $52,000
Q2 2022

Aug 15, 2022

SELL
$3.27 - $8.76 $333,170 - $892,530
-101,887 Reduced 82.09%
22,233 $77,000
Q1 2022

May 11, 2022

BUY
$7.56 - $14.3 $13,146 - $24,867
1,739 Added 1.42%
124,120 $1.02 Million
Q4 2021

Feb 11, 2022

SELL
$12.24 - $21.25 $31,591 - $54,846
-2,581 Reduced 2.07%
122,381 $1.75 Million
Q3 2021

Nov 12, 2021

BUY
$16.69 - $26.05 $269,944 - $421,332
16,174 Added 14.87%
124,962 $2.4 Million
Q2 2021

Aug 11, 2021

BUY
$18.15 - $27.75 $333,125 - $509,323
18,354 Added 20.3%
108,788 $2.75 Million
Q1 2021

May 13, 2021

BUY
$20.71 - $51.02 $58,153 - $143,264
2,808 Added 3.2%
90,434 $2.23 Million
Q4 2020

Feb 09, 2021

BUY
$21.84 - $44.0 $418,541 - $843,216
19,164 Added 27.99%
87,626 $3.21 Million
Q3 2020

Nov 12, 2020

BUY
$13.63 - $24.12 $264,094 - $467,349
19,376 Added 39.47%
68,462 $1.48 Million
Q2 2020

Aug 12, 2020

SELL
$7.65 - $14.11 $8,828 - $16,282
-1,154 Reduced 2.3%
49,086 $636,000
Q1 2020

May 06, 2020

BUY
$4.75 - $12.41 $112,465 - $293,831
23,677 Added 89.14%
50,240 $405,000
Q4 2019

Feb 14, 2020

SELL
$8.73 - $12.95 $196,276 - $291,154
-22,483 Reduced 45.84%
26,563 $289,000
Q3 2019

Nov 07, 2019

BUY
$14.16 - $25.34 $165,700 - $296,528
11,702 Added 31.34%
49,046 $719,000
Q2 2019

Aug 12, 2019

BUY
$27.0 - $30.25 $1.01 Million - $1.13 Million
37,344 New
37,344 $1.01 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $223M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.